1-4 of 4
Nila U. Parikh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer

Christine M. Parseghian, Nila U. Parikh, Ji Yuan Wu, Zhi-Qin Jiang, Laura Henderson, Feng Tian, Brice Pastor, Marc Ychou, Kanwal Raghav, Arvind Dasari, David R. Fogelman, Anastasia D. Katsiampoura, David G. Menter, Robert A. Wolff, Cathy Eng, Michael J. Overman, Alain R. Thierry, Gary E. Gallick, Scott Kopetz
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4146–4154.
https://doi.org/10.1158/1078-0432.CCR-16-3138
Published: 01 August 2017
View article titled, Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer
Open the PDF for Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer

Andreas Varkaris, Paul G. Corn, Nila U. Parikh, Eleni Efstathiou, Jian H. Song, Yu-Chen Lee, Ana Aparicio, Anh G. Hoang, Sanchaika Gaur, Lynnelle Thorpe, Sankar N. Maity, Menashe Bar Eli, Bogdan A. Czerniak, Yiping Shao, Mian Alauddin, Sue-Hwa Lin, Christopher J. Logothetis, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 107–121.
https://doi.org/10.1158/1078-0432.CCR-15-0235
Published: 03 January 2016
View article titled, Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer
Open the PDF for Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness

Douglas D. Boyd, Heng Wang, Hector Avila, Nila U. Parikh, Horst Kessler, Victor Magdolen, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1545–1555.
https://doi.org/10.1158/1078-0432.CCR-1565-02
Published: 20 February 2004
View article titled, Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes <em>in Vitro</em> Colon Cancer Invasiveness
Open the PDF for Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes <em>in Vitro</em> Colon Cancer Invasiveness in another window
Journal Articles

Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells

Michael A. Davies, Sun J. Kim, Nila U. Parikh, Zhongyun Dong, Corazon D. Bucana, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1904–1914.
Published: 01 June 2002
View article titled, Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells
Open the PDF for Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells in another window